Prostate Cancer
Latest News
What the first authorized DNA cancer risk test can and can’t tell you
The test can identify genetic variants that increase an individual’s risk of certain cancers and help identify potential cancer-related hereditary...
Conference Coverage
Short-course SBRT: Standard of care in prostate cancer?
Stereotactic body radiation therapy delivered in five fractions provided similar 5-year disease control as conventional, higher-dose external-beam...
From the Journals
Cost concerns lead to cancer treatment delays, nonadherence
Hospital-based financial navigators may help cancer patients negotiate the intricacies of insurance coverage, experts suggest.
From the Journals
Cancer incidence has increased in patients under age 50
“Prevention and early detection measures are urgently required, along with identifying optimal treatment strategies for early-onset cancers, which...
Latest News
Survey: Lack of awareness hampers cancer prevention efforts
Various guidelines that address physicians' role in patient awareness and knowledge focus on assessing patient needs and readiness to learn,...
Latest News
Is this the best screening test for prostate cancer?
Researchers from the United Kingdom found that half of men with apparently “safe” PSA levels had clinically significant prostate cancers when...
Latest News
BCR is unreliable surrogate for overall survival in prostate cancer
The correlation between BCR-free survival and overall survival ranged from low to moderate.
Latest News
Predicting prostate cancer risk: Are polygenic risk scores ready for prime time?
“A polygenic risk score estimates your risk by adding together the number of bad cards you were dealt by the impact of each card, such as an ace...
From the Journals
Do AI chatbots give reliable answers on cancer? Yes and no
“The chatbot was most likely to mix in incorrect recommendations among correct ones, an error difficult even for experts to detect.”
Feature
New trials in prostate cancer: Could your patient benefit?
Several new trials have opened in recent months.
From the Journals
Risky drinking common in cancer survivors
The numbers are “staggering. Most concerning ... is that those on cancer treatment are engaged in a similar level of risky drinking.”